Ind-Swift Laboratories Share Price
Know More₹108.12 2.12 (2.00%)
20-Dec-2024₹107.11 2.10 (2.00%)
20-Dec-2024BSE : 532305
NSE : INDSWFTLAB
Sector : Health care
ISIN Code : INE915B01019
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 20-Dec-2024
| Market Cap (₹ Cr) | 639 |
Traded Value (₹ Cr) | 0.28 |
Volume (Shares) | 26,357 |
Face Value (₹) | 10 |
52-Week High (₹) | 186.00 |
52-Week High Date | 02-Aug-2024 |
52-Week Low (₹) | 87.00 |
52-Week Low Date | 03-Dec-2024 |
All Time High (₹) | 297.35 |
All Time High Date | 22-Dec-2004 |
All Time Low (₹) | 13.25 |
All Time Low Date | 31-Mar-2003 |
Ind-Swift Laboratories Ltd
Market News
Ind-Swift Laboratories Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 633 |
| EPS - TTM (₹) [C] | 17.29 |
| P/E Ratio (X) [C] | 6.19 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 10.00 |
| Latest Dividend Date | 20-Sep-2011 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 171.20 |
| P/B Ratio (₹) [C] | 0.63 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.00 | 343 | 0.03 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 105.00 107.11 |
| Week Low/High (₹) | 105.00 113.00 |
| Month Low/High (₹) | 86.20 120.00 |
| Year Low/High (₹) | 86.20 186.00 |
| All time Low/High (₹) | 13.25 297.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -6.78% | -5.53% | -4.98 | -4.77% |
| 1 Month | 1.05% | 2.99% | 0.60 | 0.29% |
| 3 Month | -22.61% | -21.73% | -7.69 | -8.54% |
| 6 Month | -8.41% | -8.66% | 0.73 | 0.09% |
| 1 Year | 17.85% | 18.22% | 10.69 | 11.52% |
| 3 Year | 61.07% | 62.41% | 39.80 | 41.97% |
Company Info
Company Information
Chairman & Managing Director : N R Munjal
Joint Managing Director : Himanshu Jain
Company Sec. & Compli. Officer : Pradeep Verma
Executive Director : Rishav Mehta
Independent Director : S P Sharma
Independent Director : Neerja Chathley
Independent Director : Ashwani K Vig
Executive Director : Sahil Munjal
Independent Director : Rajendra Kumar Gupta
Registered Office: SCO 850 Shivalik Enclave, NAC Manimajra,Chandigarh,Chandigarh-160101 Ph: 91-0172-5061850/2730920
FAQs about Ind-Swift Laboratories Ltd
1. What's the Ind-Swift Laboratories Ltd share price today?
Ind-Swift Laboratories Ltd share price was Rs 108.12 at close on 20th Dec 2024. Ind-Swift Laboratories Ltd share price was up by 2.00% over the previous closing price of Rs 106.00. Ind-Swift Laboratories Ltd share price trend:
- Last 1 Month: Ind-Swift Laboratories Ltd share price moved up by 1.05% on BSE
- Last 3 Months: Ind-Swift Laboratories Ltd share price moved down by 22.61% on BSE
- Last 12 Months: Ind-Swift Laboratories Ltd share price moved up by 17.85% on BSE
- Last 3 Years: Ind-Swift Laboratories Ltd price moved up by 61.07% on BSE
2. How can I quickly analyse the performance of the Ind-Swift Laboratories Ltd stock?
The performance of the Ind-Swift Laboratories Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 6.19
- Price to book value ratio is 0.63
- Dividend yield of 0.00
- The EPS (trailing 12 months) of the Ind-Swift Laboratories Ltd stock is Rs 17.29
3. What is the market cap of Ind-Swift Laboratories Ltd?
Ind-Swift Laboratories Ltd has a market capitalisation of Rs 639 crore.
4. What is Ind-Swift Laboratories Ltd's 52-week high/low share price?
The Ind-Swift Laboratories Ltd’s 52-week high share price is Rs 186.00 and 52-week low share price is Rs 87.00.
5. Is the Ind-Swift Laboratories Ltd profitable?
On a consolidated basis, Ind-Swift Laboratories Ltd reported a profit of Rs 0.32 crore on a total income of Rs 15.66 crore for the quarter ended 2024. For the year ended Sep 2024, Ind-Swift Laboratories Ltd had posted a profit of Rs 0.40 crore on a total income of Rs 24.96 crore.
6. Which are Ind-Swift Laboratories Ltd’s peers in the Health care sector?
Ind-Swift Laboratories Ltd’s top 5 peers in the Health care sector are Shree Ganesh Rem, Albert David, Medicamen Biotec, Ind-Swift Labs., Megasoft, Titan Biotech, Jenburkt Pharma.
7. Who owns how much in Ind-Swift Laboratories Ltd?
Key changes to the Ind-Swift Laboratories Ltd shareholding are as follows:
- Promoter holding in Ind-Swift Laboratories Ltd has gone up to 42.00 per cent as of Sep 2024 from 42.00 per cent as of Mar 2024.
